Back to search

Article

Study on the mechanism of Euscaphic acid in the treatment of non-Hodgkin lymphoma based on network pharmacology and molecular docking

2024-02-09

Abstract excerpt

Non-Hodgkin's lymphoma (NHL) is a highly heterogenous disease. 5-year survival duration after diagnosis is poor among patients with aggressive/relapsing form of NHL. Our previous research found for the first time that Euscaphic acid (EA) has anti-tumor effects in NHL. However, the underlying mechanism by which EA plays a role in NHL remains unclear. In this study, we used network pharmacology and molecular docking...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
4470943a-db6a-52b9-96a7-2ec7e302b00e
DOI
10.21203/rs.3.rs-3926002/v1
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
Study on the mechanism of Euscaphic acid in the treatment of non-Hodgkin lymphoma based on network pharmacology and molecular dockingDOI 10.21203/rs.3.rs-3926002/v1
Select a neighboring publication to make it the new centre.